LeukemiaRituxan Hycela coupons
Rituxan Hycela

Rituxan Hycela Coupons & Discount Card - Compare Prices Near You

Rituximab, marketed as Rituxan Hycela, is a medication used to treat specific blood cancers, including non-Hodgkin's lymphoma, chronic lymphocytic leukemia, follicular lymphoma, and diffuse large B-cell lymphoma. This drug combines rituximab, an anti-CD20 monoclonal antibody, with hyaluronidase, an enzyme that enhances absorption when administered subcutaneously. Rituximab works by targeting and binding to a protein called CD20 on B cells, which are part of the immune system and may become cancerous. This binding signals the immune system to destroy these abnormal cells, thereby inhibiting their growth and spread. Rituxan Hycela is usually administered every one to three weeks, depending on the patient's condition, and is suitable for individuals who have previously received rituximab intravenously. Potential side effects include allergic reactions, infections, and skin issues.
Our Rituxan Hycela coupons are free to use. You can print the coupon, email it to yourself, or receive the Rituxan Hycela coupon via text message. To get your free discount, show the pharmacist your Rituxan Hycela savings card which has the discounted coupon price. Use our filters below to edit the prescription box to match your needs. The Rituxan Hycela prices will update based on your prescription needs. Above our Rituxan Hycela coupons, you can change the location to see pharmacy prices in other areas. Our prescription discount card will update online with the specific pharmacy costs associated with your edits. Be sure to text, email, or print the Rituxan Hycela savings card code that you need after editing the prescription box and location field. Show the discount card to your pharmacist before paying.

My prescription

Edit

11.7ML of 1400-23400 MG-UT/11.7ML, Rituxan Hycela (1 Vial)

Select pharmacy

Pharmacy logo

Rite Aid

$6541.29

COUPON PRICE
Pharmacy logo

Walgreens

$6818.49

COUPON PRICE

Rituxan Hycela savings card

Show this card to your pharmacist
Pharmacy logo

Rite Aid

$6541.29

BIN

ID

PCN

GRP

019876

LH6F76D449

CHIPPO

LHX

Powered by

This card is not insurance

More prescriptions for leukemia

coupons from$6591.53Save 72%
coupons from$7478.59Save 72%
coupons from$51848.31 
coupons from$27.75Save 81%
coupons from$15126.18 
coupons from$15163.48 
coupons from$7371.67Save 72%
coupons from$36324.19 

More prescriptions for leukemia

Rydapt Save 72%coupons from $6591.53
Tabloid Save 72%coupons from $7478.59
Inqovicoupons from $51848.31
Mercaptopurine Save 81%coupons from $27.75
Copiktracoupons from $15126.18
Tibsovocoupons from $15163.48
Zydelig Save 72%coupons from $7371.67
Idhifacoupons from $36324.19

Rituxan Hycela dosage forms

The average cost for 1 Vial of Rituxan Hycela at 11.7ML of 1400-23400 MG-UT/11.7ML is $6630.95 with a free coupon. This is 27.95% off the average retail price of $23724.67
DosageQuantityPrice fromPer unit
11.7ML of 1400-23400 MG-UT/11.7ML1 Vial$6630.95$6630.95
13.4ML of 1600-26800 MG-UT/13.4ML1 Vial$7577.97$7577.97

Rituxan Hycela Warnings

Rituximab is a medication that can lead to severe or even life-threatening side effects. Below are important safety details and warnings you should be aware of:

  • Severe Breathing and Heart Issues: Some individuals may experience serious respiratory or cardiac complications, including irregular heartbeat or heart attack, often after the initial intravenous infusion. Seek immediate medical assistance if you encounter breathing difficulties, swelling (particularly of the throat or lips), dizziness, or chest pain.

  • Serious Skin Reactions: Rarely, rituximab may cause severe skin conditions like Stevens-Johnson syndrome or toxic epidermal necrolysis. Notify your healthcare provider immediately if you notice symptoms such as rashes, blistering, peeling skin, or sores.

  • Progressive Multifocal Leukoencephalopathy (PML): This medication may rarely lead to a serious brain infection, potentially resulting in brain damage. If you experience symptoms such as loss of coordination, weakness, changes in thinking, difficulty speaking or walking, vision changes, or seizures, contact your doctor right away.

  • Hepatitis B Reactivation: Individuals with a history of hepatitis B may experience a reactivation of the virus. Prior to starting treatment, your doctor will conduct a hepatitis B test. Notify your healthcare provider if you experience symptoms like nausea, loss of appetite, abdominal pain, dark urine, or yellowing skin/eyes.

  • Infusion-Related Reactions: During the first rituximab infusion, there is a risk of hypersensitivity reactions. Symptoms might include rash, difficulty breathing, or fever. Treatment should be administered as an intravenous infusion initially to manage any reactions promptly.

  • Tumor Lysis Syndrome: This condition can occur when cancer cells release their contents into the bloodstream, leading to potential organ damage. It is most common during the first treatment cycle. Report any signs such as nausea, fatigue, or loss of appetite promptly.

  • Infection Risks: Rituximab can increase susceptibility to serious infections. Symptoms like fever, chills, muscle aches, or severe fatigue should prompt immediate consultation with your healthcare provider.

  • Cardiac Concerns: Serious heart issues, including irregular rhythms or heart attacks, may occur. Your doctor might monitor your heart function closely during treatment.

  • Kidney and Gastrointestinal Issues: Some individuals may experience kidney problems or gastrointestinal complications, such as intestinal blockages or tears. Report any persistent stomach pain or nausea to your healthcare provider.

  • Vaccination Precautions: Ensure all vaccinations are current before starting treatment. Live vaccines should be avoided during rituximab therapy, and inactivated vaccines should be administered at least four weeks prior to starting treatment.

  • Pregnancy Risks: Rituximab can be harmful to an unborn child. Women capable of becoming pregnant should use effective contraception during and for 12 months after treatment. Inform your oncologist immediately if you become pregnant while on rituximab.

In case of an overdose or any severe reactions, seek emergency medical attention immediately. Always follow your healthcare provider’s guidance and report any concerning symptoms promptly.

Rituxan Hycela Side Effects

When using this medication, some common side effects may occur, but they are usually mild and manageable. These include pain, redness, bruising, or itching at the injection site, headache, nausea, weakness, dizziness, and tiredness. Other frequently reported effects are a lower white blood cell count, nausea, fever, constipation, hair loss, a lower platelet count, cough, vomiting, diarrhea, numbness, and tingling. If any of these symptoms persist or worsen, it's advisable to contact a healthcare provider.

There are more serious side effects that, although less common, require immediate medical attention. These include signs of stomach or intestinal blockage such as persistent vomiting or abdominal pain, increased thirst or urination, and swelling or tingling of the hands or feet. A decrease in blood cells can lead to bleeding problems and infections, so watch for easy bruising, black stools, or signs of infection like a persistent sore throat.

Rituximab can sometimes cause tumor lysis syndrome, characterized by symptoms like flank pain, kidney issues (like painful or bloody urination), or muscle spasms. Allergic reactions, though rare, can manifest as a rash, severe dizziness, or difficulty breathing and also require urgent care. Serious side effects like infusion-related reactions, severe skin reactions, gut tears, or serious heart issues warrant immediate medical attention. Always stay vigilant and consult a healthcare provider for any concerns.

Rituxan Hycela Interactions

Certain medications, including natalizumab, fingolimod, and tofacitinib, can interact with this drug. These interactions may occur because these drugs can suppress the immune system or elevate the risk of infections. If you are using any of these medications, consult your healthcare provider for guidance.
Rituxan Hycela FAQs
What is the drug RITUXAN HYCELA used for?

Rituxan Hycela is used for the treatment of certain types of blood cancers, including non-Hodgkin's lymphoma and chronic lymphocytic leukemia. It is also used for some autoimmune conditions, such as rheumatoid arthritis.

RITUXAN and RITUXAN HYCELA both contain rituximab, but they differ in their formulation and administration. RITUXAN is administered intravenously, while RITUXAN HYCELA is a subcutaneous injection that combines rituximab with hyaluronidase, an enzyme that helps with absorption under the skin. This allows RITUXAN HYCELA to be administered more quickly compared to the intravenous infusion of RITUXAN.

Rituxan (rituximab) is not a traditional chemotherapy drug. It is a monoclonal antibody used as a targeted therapy to treat certain types of cancer, such as non-Hodgkin's lymphoma and chronic lymphocytic leukemia, as well as some autoimmune diseases like rheumatoid arthritis. It works by targeting specific proteins on the surface of certain cells, helping the immune system to destroy them.

The cost of RITUXAN HYCELA can vary based on factors such as location, insurance coverage, and the healthcare provider. It is recommended to contact a pharmacy or healthcare provider directly for the most accurate and up-to-date pricing information. Additionally, insurance plans may cover part of the cost, so checking with the insurance provider is advisable.

After a Rituxan infusion, individuals may experience a range of side effects. Commonly reported immediate reactions include fever, chills, nausea, headache, and fatigue. Some people might also experience itching or rash. These infusion-related reactions typically occur during or shortly after the infusion. It's important for patients to communicate any discomfort to their healthcare provider during the infusion, as they can manage these symptoms effectively. Long-term side effects can vary, and patients should discuss any concerns with their healthcare provider.